Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Unknown 4Completed 2

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Gastrointestinal 156Other neoplasm 2Other 2Thoracic 1Head & Neck 1

Conditions

Precancerous Conditions 145Lymphoma 34Leukemia 32Multiple Myeloma 31Neoplasms, Plasma Cell 30Monoclonal Gammopathy of Undetermined Significance 30Lymphoma, Non-Hodgkin 29Lymphoma, Mantle-Cell 29Lymphoma, Large-Cell, Immunoblastic 29Lymphoma, Large B-Cell, Diffuse 29Lymphoma, Follicular 29Leukemia, Lymphocytic, Chronic, B-Cell 29Precursor Cell Lymphoblastic Leukemia-Lymphoma 28Lymphoma, B-Cell, Marginal Zone 28Burkitt Lymphoma 28Immunoglobulin Light-chain Amyloidosis 27Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 26Hodgkin Disease 26Waldenstrom Macroglobulinemia 25Myeloproliferative Disorders 25Immunoblastic Lymphadenopathy 25Myelodysplastic Syndromes 24Lymphoma, Large-Cell, Anaplastic 24Leukemia, Hairy Cell 24Thrombocythemia, Essential 23Primary Myelofibrosis 23Leukemia, Myeloid, Acute 23Leukemia, Large Granular Lymphocytic 23Lymphoma, T-Cell, Cutaneous 22Leukemia, Prolymphocytic 22

Interventions

Esomeprazole 1Aspirin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Barrett Esophagus × Other neoplasm × Clear all
NCT00357682 2025-05-01

AspECT

University of Oxford

Phase 3 Completed
2,557 enrolled 17 charts
GastrointestinalOther neoplasm

Barrett Esophagus, Esophageal Neoplasms, Precancerous Conditions

NCT00445653 2017-01-18

Risk Factors for Barrett's Esophagus in Patients With BE, Gastroesophageal Reflux, or Gastrointestinal Bleeding

Massachusetts General Hospital

Completed
170 enrolled
GastrointestinalOther neoplasm

Barrett Esophagus, Precancerous Conditions

Data powered by HemOnc (CC BY 4.0) Colophon âš¡